MERIDIAN BIOSCIENCE INC of CINCINNATI, OH filed a DEFA14A with the SEC on 2022-07-07. Industry: In Vitro & In Vivo Diagnostic Substances.
| Seq | Type | Description |
|---|---|---|
| 1 | DEFA14A | DEFA14A |
| 2 | GRAPHIC | GRAPHIC |
| 3 | GRAPHIC | GRAPHIC |
| 4 | GRAPHIC | GRAPHIC |
| 5 | GRAPHIC | GRAPHIC |
| 6 | GRAPHIC | GRAPHIC |
| 7 | GRAPHIC | GRAPHIC |
| 8 | GRAPHIC | GRAPHIC |
| 9 | GRAPHIC | GRAPHIC |
| 10 | GRAPHIC | GRAPHIC |
| 11 | GRAPHIC | GRAPHIC |
| 12 | GRAPHIC | GRAPHIC |
| 13 | GRAPHIC | GRAPHIC |
| 14 | GRAPHIC | GRAPHIC |
| 15 | GRAPHIC | GRAPHIC |
Showing 12 of 46 filings.
| Filed | Form |
|---|---|
| 2022-09-30 | DEFA14A |
| 2022-09-08 | DEFM14A |
| 2022-08-25 | PREM14A |
| 2022-07-08 | DEFA14A |
| 2022-07-07 | DEFA14A |
| 2022-07-07 | DEFA14A |
| 2022-07-07 | DEFA14A |
| 2022-07-07 | DEFA14A |
| 2021-12-15 | DEFA14A |
| 2021-12-15 | DEF 14A |
| 2021-01-12 | DEFA14A |
| 2020-12-30 | DEFA14A |